BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:ADU-1805 readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of ADU-1805\, from ClinicalTrials.gov estima
 tes.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT05856981-2329@assetmemo.bio
DTSTAMP:20261121T005648Z
DTSTART;VALUE=DATE:20270531
DTEND;VALUE=DATE:20270601
SUMMARY:ADU-1805: Phase 1 readout est. (NCT05856981)
DESCRIPTION:ADU-1805\, phase 1\, Non-Small Cell Lung Cancer.\nStudy: Phase 
 1 Study Evaluating the Safety and PK of ADU-1805 in Advanced Solid Tumors\
 nEstimated primary completion: May 2027. This is a ClinicalTrials.gov esti
 mate\, not a confirmed readout date\, and it can move.\nDrug page: https:/
 /assetmemo.bio/drug/adu-1805#upcoming-events\nRegistry record: https://cli
 nicaltrials.gov/study/NCT05856981
URL:https://assetmemo.bio/drug/adu-1805#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
